We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Protocol demonstrates interventions for alzheimer's-related cognitive decline, suggesting potential benefits for patients.
Protocol (2025): PROSPERO registration number CRD420251114325.
No takes yet. Share an insight, caveat, or question.
Nonino et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: